LGALS3 and cardiomyopathy: Firstly, in this small population, there may be patients with “hidden” pathology, i.e., in the occult/initial phase of disease with a relatively large ventricle, suppressed contractile function and high galectin-3 plasma concentration, but who still do not meet criteria for the diagnosis of a cardiomyopathy.